Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00506519

Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis

Disseminated Intravascular Coagulation Clinical Trial

Official title:
Exploratory Efficacy and Safety, Pharmacokinetics and Dose Finding Study of ATryn® (Antithrombin Alfa) in Patients With Disseminated Intravascular Coagulation Associated With Severe Sepsis

Clinical Trial Summary

The primary objective of the study is to explore the efficacy and safety of ATryn® (antithrombin alfa) for the treatment of disseminated intravascular coagulation (DIC) associated with severe sepsis, when administered by continuous intravenous (IV) infusion over five days.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Disseminated Intravascular Coagulation
  • Sepsis
Clinical Trial Details
NCT number NCT00506519
Study type Interventional
Source LEO Pharma
Contact
Status Terminated
Phase Phase 2
Start date July 2007
Completion date March 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT04580563 - Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study N/A
Completed NCT01704001 - Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment Phase 4
Terminated NCT00299949 - Thrombin Generation and Thromboelastography in Non-overt DIC N/A
Recruiting NCT03577015 - International Prospective Registry of Disseminated Intravascular Coagulation
Withdrawn NCT04363840 - The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations Phase 2
Completed NCT04873349 - Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients N/A
Withdrawn NCT01090115 - Study to Look at the Effects of ART-123 on Patients With Sepsis and Disseminated Intravascular Coagulation (DIC) Phase 2
Active, not recruiting NCT04107402 - PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock N/A
Completed NCT00487656 - Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation Phase 2
Completed NCT03714048 - Blood Management During ECMO for Cardiac Support
Completed NCT04547153 - Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC Phase 2
Recruiting NCT05995093 - The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation
Completed NCT04460664 - Coagulation Changes Associated With COVID-19 Infection
Completed NCT04356950 - Analysis of the Coagulopathy Developed by COVID-19 Infected Patients
Completed NCT04356144 - Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections
Recruiting NCT06363149 - Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock Patients
Recruiting NCT02654561 - Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation Phase 3
Active, not recruiting NCT06373159 - An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan
Completed NCT03716310 - Platelet Reactivity in Septic Shock